Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: A prospective study

BACKGROUND: The contraceptive skin patch (CSP) accepted by the U.S. FDA in 2001 includes ethinylestradiol and norelgestromine, whereas the subdermal contraceptive implant (SCI) has etonogestrel and is also approved by the FDA. In Mexico, both are now widely used for contraception but their effects o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez-Juarez, Jesus, Garcia-Latorre, Ethel A, Moreno-Hernandez, Manuel, Moran-Perez, Jose Fernando, Rodriguez-Escobedo, Miguel Angel, Cogque-Hernandez, Gerardo, Julián-Nacer, Rubén, Hernandez-Giron, Xochitl, Palafox-Gomez, Rosalia, Isordia-Salas, Irma, Majluf-Cruz, Abraham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044294/
https://www.ncbi.nlm.nih.gov/pubmed/24767248
http://dx.doi.org/10.1186/1742-4755-11-33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044294/
https://www.ncbi.nlm.nih.gov/pubmed/24767248
http://dx.doi.org/10.1186/1742-4755-11-33

Ejemplares similares